Meropenem Acs Dobfar

Meropenem, the active ingredient in Meropenem Acs Dobfar, is a carbapenem antibiotic presented as an IV solution for intravenous use. It treats severe bacterial infections such as complicated intra‑abdominal infections, urinary tract infections, pneumonia, meningitis, and sepsis in hospitalized patients.

GNH USA supplies Meropenem Acs Dobfar as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres and pharmacies worldwide.

Meropenem is a carbapenem antibiotic used to treat serious bacterial infections across several organ systems.

- Complicated intra‑abdominal infections: provides rapid bacterial eradication in patients with intra‑abdominal sepsis. - Complicated urinary tract infections: clears resistant uropathogens causing severe UTIs. - Nosocomial pneumonia: effective against hospital‑acquired lung infections. - Community‑acquired pneumonia: treats severe community‑origin bacterial pneumonia. - Meningitis: penetrates the cerebrospinal fluid to combat bacterial meningitis. - Severe sepsis: broad‑spectrum activity supports management of systemic infection.

Adverse reactions may occur with meropenem therapy.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: may be watery and self‑limiting. - Vomiting: occasional emesis during infusion. - Headache: transient headache reported. - Infusion site reactions: erythema or phlebitis at the injection site. - Elevated liver enzymes: transient increase in transaminases.

Serious or Rare Side Effects: - Seizures: risk increased in patients with renal impairment or CNS disorders. - Severe allergic reactions: anaphylaxis or Stevens‑Johnson syndrome. - Clostridioides difficile colitis: possible severe diarrhea. - Renal impairment: acute kidney injury in susceptible individuals. - Thrombocytopenia: low platelet counts requiring monitoring. - Anaphylaxis: immediate hypersensitivity requiring emergency care.

Careful assessment and monitoring are required when using meropenem. - Renal function: adjust dose in patients with impaired renal clearance. - Seizure risk: monitor patients with a history of CNS disorders. - Allergy: avoid in individuals with known hypersensitivity to carbapenems. - Pregnancy: use only if the potential benefit justifies the potential risk to the fetus. - Drug interactions: review concomitant medications for potential interactions. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Meropenem may interact with several concomitant medications.

Major Interactions (Avoid): - Valproic acid: may reduce serum levels, increasing seizure risk. - Cisplatin: combined use can enhance nephrotoxicity. - Probenecid: may increase meropenem plasma concentrations. - Other β‑lactam antibiotics: potential antagonistic effects.

Moderate Interactions (Monitor Closely): - Aminoglycosides: additive nephrotoxic potential. - Loop diuretics: may affect renal clearance of meropenem. - Warfarin: monitor INR for possible anticoagulant effect changes.